
Malignancies are a major cause of morbidity and mortality zzso Cancer is a cell disease, characterized by a zzso of the control mechanisms of proliferation and differentiation of zzso Among the treatments available, chemotherapy is often the first zzso zzso are a new class of zzso drugs that act by interacting with cellular zzso interrupting the proliferation of cancer zzso Many synthetic and zzso zzso of zzso have been prepared aiming improvement in effectiveness and zzso based on zzso zzso These zzso have been effective for treatment of tumors resistant to zzso zzso Six new zzso are being subjected to clinical zzso zzso zzso was approved by zzso in 2007, zzso is in phase III clinical trial for zzso and zzso zzso zzso zzso and zzso are in phase II clinical trials, for the treatment of zzso zzso and advanced zzso breast cancer, zzso breast cancer and zzso pulmonary cancer, zzso zzso reached only phase II trials and zzso reached phase zzso trials, but were not approved for clinical use due to adverse effects such as zzso and severe zzso which were zzso Furthermore, the low zzso zzso in comparison with other class zzso does not recommend the clinical use of this zzso Some other zzso zzso presented zzso activity in zzso but are not yet submitted to clinical zzso zzso and zzso are adverse effects presented by some substances of this class of zzso zzso 

